Clinical trial
Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer
NCT01245712 · M.D. Anderson Cancer Center, Other · Active, not recruiting
Key facts
| NCT number | NCT01245712 |
|---|---|
| Title | Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer |
| Official title | Assessing the Cosmesis and Toxicity of Partial Breast Irradiation Using Proton Beam Irradiation |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Active, not recruiting |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Adenocarcinoma, Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma, Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7 |
| Intervention type | Other, Radiation |
| Interventions | Accelerated Partial Breast Irradiation, Proton Beam Radiation Therapy, Quality-of-Life Assessment |
| Enrollment | 200 |
| Start date | Nov 15, 2010 |
| Primary completion | Dec 31, 2032 |
| Completion | Dec 31, 2032 |
| First posted | Nov 22, 2010 |
| Last update posted | Dec 17, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: